Since CTNNB1 mutations are also common in ovarian endometrioid carcinoma (even more than in its endometrial counterpart [43]), it cannot be excluded that CTNNB1 status might also be clinically useful in ovarian carcinoma. Here, CTNNB1 is linked to ovarian carcinoma.